Remembering Stephen F. Heinemann

Posted: Aug. 27, 2014

Cure Alzheimer's Fund is saddened by the recent passing of Stephen F. Heinemann, a pioneer in brain disease research and a former member of our Scientific Advisory Board. Dr. Heinemann, who was based at the Salk Institute for Biological Studies, passed away earlier this month at age 75.

Heinemann's work provided groundbreaking insight into the way deficits in communication between neurons in the brain can contribute to a variety of neurological diseases and conditions, from Alzheimer's and Parkinson's to schizophrenia and bipolar disorder. Additionally, his lab identified a gene containing blueprints for a receptor critical to learning and memory. Heinemann was especially concerned with Alzheimer's disease and warned of a coming epidemic that could overwhelm the country's medical system.

William Brody, president of the Salk Institute, calls Heinemann a "giant of twentieth century neuroscience", and adds that "his discoveries opened many avenues to better understand the function of the brain." 

We remember Dr. Heinemann for his incredible contributions to research and his personal commitment to curing Alzheimer's disease.